Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

532 ARTÍCULOS , VIENDO DEL 436 AL 450

Functional Foods: An Approach to Modulate Molecular Mechanisms of Alzheimer's Disease

Atlante A, Amadoro G, Bobba A, Latina V.

Cells. 2020 Oct 23;9(11):2347. doi: 10.3390/cells9112347.

CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment

Gaetani L, Paolini Paoletti F, Bellomo G, Mancini A, Simoni S, Di Filippo M, Parnetti L.

Trends Pharmacol Sci. 2020 Dec;41(12):1023-1037. doi: 10.1016/j.tips.2020.09.011. Epub 2020 Oct 27.

Applications of iTRAQ and TMT Labeling Techniques to the Study of Neurodegenerative Diseases

Li K, Chen Z, Zhang Y, Yang X.

Curr Protein Pept Sci. 2020;21(12):1202-1217. doi: 10.2174/1389203721666201103085704.

Current Progress and Future Directions for Tau-Based Fluid Biomarker Diagnostics in Alzheimer's Disease

Arastoo M, Lofthouse R, Penny LK, Harrington CR, Porter A, Wischik CM, Palliyil S.

Int J Mol Sci. 2020 Nov 17;21(22):8673. doi: 10.3390/ijms21228673.

Sigma-2 Receptor-A Potential Target for Cancer/Alzheimer's Disease Treatment via Its Regulation of Cholesterol Homeostasis

Yang K, Zeng C, Wang C, Sun M, Yin D, Sun T.

Molecules. 2020 Nov 20;25(22):5439. doi: 10.3390/molecules25225439.

Improvements of symptoms of Alzheimer`s disease by inhibition of the angiotensin system

Quitterer U, AbdAlla S.

Pharmacol Res. 2020 Apr;154:104230. doi: 10.1016/j.phrs.2019.04.014. Epub 2019 Apr 13.

Autophagy Dysfunction in Alzheimer's Disease: Mechanistic Insights and New Therapeutic Opportunities

Di Meco A, Curtis ME, Lauretti E, Praticò D.

Biol Psychiatry. 2020 May 1;87(9):797-807. doi: 10.1016/j.biopsych.2019.05.008. Epub 2019 May 20.

Advance of sporadic Alzheimer's disease animal models

Zhang L, Chen C, Mak MS, Lu J, Wu Z, Chen Q, Han Y, Li Y, Pi R.

Med Res Rev. 2020 Jan;40(1):431-458. doi: 10.1002/med.21624. Epub 2019 Jul 22.

BACE1 inhibitors: Current status and future directions in treating Alzheimer's disease

Moussa-Pacha NM, Abdin SM, Omar HA, Alniss H, Al-Tel TH.

Med Res Rev. 2020 Jan;40(1):339-384. doi: 10.1002/med.21622. Epub 2019 Jul 26.

How plausible is an Alzheimer's disease vaccine?

Cacabelos R.

Expert Opin Drug Discov. 2020 Jan;15(1):1-6. doi: 10.1080/17460441.2019.1667329. Epub 2019 Sep 17.

Comparative pharmacokinetic study of the components in Alpinia oxyphylla Miq.-Schisandra chinensis (Turcz.) Baill. herb pair and its single herb between normal and Alzheimer's disease rats by UPLC-MS/MS

Qi Y, Cheng X, Jing H, Yan T, Xiao F, Wu B, Bi K, Jia Y.

J Pharm Biomed Anal. 2020 Jan 5;177:112874. doi: 10.1016/j.jpba.2019.112874. Epub 2019 Sep 12.

Mitochondrial calcium uniporter as a potential therapeutic strategy for Alzheimer's disease

Venugopal A, Iyer M, Balasubramanian V, Vellingiri B.

Acta Neuropsychiatr. 2020 Apr;32(2):65-71. doi: 10.1017/neu.2019.39. Epub 2019 Dec 26.

How does a researcher choose the best rodent model for their Alzheimer's disease drug discovery study?

Van Dam D, De Deyn PP.

Expert Opin Drug Discov. 2020 Mar;15(3):269-271. doi: 10.1080/17460441.2020.1676719. Epub 2019 Oct 8.

Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer's disease from a ferroptosis perspective

Derry PJ, Hegde ML, Jackson GR, Kayed R, Tour JM, Tsai AL, Kent TA.

Prog Neurobiol. 2020 Jan;184:101716. doi: 10.1016/j.pneurobio.2019.101716. Epub 2019 Oct 8.

Cognitive Outcomes of Long-term Benzodiazepine and Related Drug (BDZR) Use in People Living With Mild to Moderate Alzheimer's Disease: Results From NILVAD

Dyer AH, Murphy C, Lawlor B, Kennelly SP; NILVAD Study Group.

J Am Med Dir Assoc. 2020 Feb;21(2):194-200. doi: 10.1016/j.jamda.2019.08.006. Epub 2019 Oct 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias